PA
ANRO icon

Perceptive Advisors’s Alto Neuroscience ANRO Stock Holding History

Perceptive Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.5M Sell
1,609,893
-400,000
-20% -$9.25M 0.64% 34
2026
Q1 		$45.2M Buy
2,009,893
+225,500
+13% +$4.18M 0.88% 28
2025
Q4 		$31.8M Buy
1,784,393
+1,629,027
+1,049% +$20.5M 0.57% 46
2025
Q3 		$625K Buy
+155,366
New +$515K 0.02% 88

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Perceptive Advisors's ANRO Position: Q2 2026 in Review

Perceptive Advisors reduced its Alto Neuroscience (ANRO) stake by 20% in Q2 2026, selling an estimated $9.25M and leaving 1,609,893 shares worth $42.5M. The position accounts for 0.64% of the portfolio, ranked #34.

Perceptive Advisors first reported a position in ANRO in Q3 2025 and has held it in 4 quarters since. The position peaked at $45.2M in Q1 2026. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Perceptive Advisors held 1,609,893 shares of Alto Neuroscience worth $42.5M as of Q2 2026.
  • Perceptive Advisors sold 400,000 Alto Neuroscience shares in Q2 2026, an estimated $9.25M.
  • Alto Neuroscience made up 0.64% of Perceptive Advisors's portfolio in Q2 2026, its #34 holding.
  • Perceptive Advisors first reported a position in Alto Neuroscience in Q3 2025 and has held it in 4 quarters since.
  • Perceptive Advisors's Alto Neuroscience position peaked at $45.2M in Q1 2026.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.